Direct antiviral therapy in patients with HCV: evidence from Saudi Arabia
HCV remains a major global health problem, with a lack of empirical data on HCV in Saudi Arabia. This study investigated the current understanding of the clinical impact of direct-acting antiviral (DAA) on HCV infection in Saudi patients.